Caladrius Biosciences, Inc.
(NASDAQ : CLBS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading CLBS News...
...
Distribution Services » Wholesale Distributors
symbolcompany%chnglast%shortavg$volume
GWWW.W. Grainger, Inc.
-0.42%239.6310.4%$129.66m
FASTFastenal Company
-0.49%50.766.3%$99.18m
HDSHD Supply Holdings, Inc.
-0.27%40.331.8%$80.36m
GPCGenuine Parts Company
-0.63%92.861.5%$60.23m
MSMMSC Industrial Direct Co., Inc. Class A
0.02%100.514.8%$48.71m
WCCWESCO International, Inc.
-0.73%67.750.6%$35.32m
INTWorld Fuel Services Corporation
-0.03%35.143.6%$28.05m
POOLPool Corporation
0.07%118.932.7%$26.71m
UNVRUnivar, Inc.
-2.10%29.411.2%$23.91m
DNOWNOW Inc
-0.93%16.017.6%$22.73m
BECNBeacon Roofing Supply, Inc.
-1.11%48.252.8%$22.34m
MRCMRC Global Inc.
-0.17%17.867.6%$20.64m
SUNSunoco LP
0.16%24.376.5%$19.07m
CORECore-Mark Holding Company, Inc.
-0.74%30.845.1%$11.88m
AITApplied Industrial Technologies, Inc.
-0.08%61.501.3%$11.65m

Company Profile

Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. The company was founded in September 1980 and is headquartered in New York, NY.